JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B6032 CB-5083

Target: p97

Summary: p97 inhibitor

insoluble in H2O; ≥20.65 mg/mL
A4447 2,3-DCPE hydrochloride

Target: Apoptosis Inducers

Summary: Bcl-XL protein expression downregulator

<30.06 mg/mL
A4453 NSC 687852 (b-AP15)

Target: Deubiquitinating enzymes (DUBs)

Summary: 19S regulatory particle Inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.95 mg/mL
A8215 PP 1

Target: Src|EGFR|JAK|ZAP-70

Summary: Src family tyrosine kinase inhibitor
A1493 ABT-751 (E7010)
1 Citation

Target: Microtubules/Tubulins

Summary: Inhibitor of microtubule polymerization,antimitotic

insoluble in H2O; ≥18.55 mg/mL
A1971 Etoposide
4 Citation

Target: Topoisomerases

Summary: Topo II inhibitor

≥112.6 mg/mL
A2451 Epirubicin HCl

Target: Topoisomerases

Summary: Antibiotic antitumor agent

≥29.00 mg/mL
A1882 Cediranib (AZD217)

Target: VEGFR

Summary: VEGFR inhibitor receptor,highly potent

≥22.52 mg/mL
A5703 BMS-777607

Target: MET

Summary: C-Met inhibitor, potent and selective

≥25.65 mg/mL
A8214 AZD8055
2 Citation

Target: mTOR

Summary: MTOR inhibitor

≥23.3 mg/mL